Skip to content
AiSeekAiSeek
Sign in
NewMarketsReported 2026-10-07 20:00

Akebia Therapeutics to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum

Akebia Therapeutics will conduct one-on-one meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum where management will discuss the company's commercial products and clinical pipeline for rare kidney diseases.

Why it matters. Investors and analysts will gain insights into the company's strategic direction and pipeline progress, affecting stock prices and investment decisions.

01

Who it touches

  1. 1Akebia Therapeutics
  2. operates in →Fact
    2biopharmaceutical industryIndustry
  3. located in →Fact
    3Waltham, MassachusettsGeography
02

Evidence

  • GGlobeNewswire public company newsCompany2026-10-07 20:00
    Akebia was founded in 2007
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 20:00
    Akebia was founded in 2007 and is headquartered in Waltham, Massachusetts.
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 20:00
    a biopharmaceutical company
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 20:00
    WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, Dr. Steven Burke, Chi…
    View source
  • GGlobeNewswire public company newsCompany2026-10-07 20:00
    During meetings, management will discuss its commercial products and clinical stage, differentiated pipeline assets for rare kidney diseases.
    View source